OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Q Exactive
(1)
Publication Date
2019
(1)
Release Date
2025
(4)
2022
(3)
2023
(2)
2021
(2)
2020
(2)
2019
(2)
2024
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA.
Not available
S-EPMC10100669
|
biostudies-literature
Cite
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Not available
S-EPMC10160525
|
biostudies-literature
Cite
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
Not available
S-EPMC7547282
|
biostudies-literature
Cite
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Not available
S-EPMC8812745
|
biostudies-literature
Cite
Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease
Not available
S-SCDT-10_1038-S44320-024-00027-8
|
biostudies-other
Cite
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Not available
S-EPMC8320276
|
biostudies-literature
Cite
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
Not available
S-EPMC9114491
|
biostudies-literature
Cite
Gut Microbial Ecosystem Multiomics in Inflammatory Bowel Disease
Using multiple omics approaches to explore the effect of the gut microbial ecosytem on inflammatory bowel disease
ORGANISM(S):
Environmental Samples <bacteria> (ncbitaxon:48479)
2019-07-02
|
MSV000084050
|
MassIVE
Cite
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.
Not available
S-EPMC12789570
|
biostudies-literature
Cite
Defining subgroups of pediatric nephrotic patients with urine proteomics.
Not available
S-EPMC12393002
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets